Are there still healthy obese patients?
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Obesity is associated with an increased risk of premature death and represents a fast growing worldwide health problem that is reaching epidemic proportions. Obesity significantly increases the risk of developing metabolic disorders, hypertension, coronary heart disease, stroke, and several types of cancer. However, a subgroup of 'healthy' obese patients seems to be protected against metabolic and cardiovascular obesity comorbidities. This review focuses on potential mechanisms underlying the healthy obese subphenotype. RECENT FINDINGS: Individuals with obesity typically develop type 2 diabetes, dyslipidemia, fatty liver disease, gout, hypertension, and cardiovascular disease. In the past years it became clear that up to 30% of obese patients are metabolically healthy with insulin sensitivity similar to healthy lean individuals, lower liver fat content, and lower intima media thickness of the carotid artery than the majority of metabolically 'unhealthy' obese patients. Recent studies suggest that protection against development of hepatic steatosis, ectopic fat deposition, inflammation of visceral adipose tissue, and adipose tissue dysfunction contributes to healthy obesity. SUMMARY: For the stratification of obesity treatment, definition of metabolically healthy or high-risk phenotypes will facilitate the identification of the obese person who will benefit the most from early lifestyle, bariatric surgery, or pharmacological interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
Guh, D. P., Zhang, W., Bansback, N., Amarsi, Z., Birmingham, C. L., & Anis, A. H. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-88 · Cited by 3,855 · cited 1×
“In addition, quality of life of obese individuals is impaired by a number of psycho-social factors, osteoarthritis, chronic pain, asthma, gallbladder disease, and metabolic disorders [7].”
BackgroundCold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058
Mechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814 · cited 1×
“Obesity is associated with an increased risk of premature death due to the significantly increased risk of developing type 2 diabetes, hypertension, coronary heart disease, stroke, and several types of cancer [5,6].”
BackgroundA Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612 · cited 1×
“As a consequence of the dramatic increase in obesity prevalence rates, life expectancy may start to decrease for the first time in recent history due to obesity-related disorders [4].”
BackgroundObesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Wildman, R. P. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1617 · Cited by 1,618
Identification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049
Ferrannini, E., Natali, A., Bell, P., Cavallo-Perin, P., Lalic, N., & Mingrone, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119628 · Cited by 898
Cited by
Chait, A., & den Hartigh, L. J. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00022 · Cited by 1,529
“Insulin-sensitiveMHO individuals tend to have lower visceral and intrahepatic fat accumulation than theirMUHO counterparts (203, 400, 401), providing further evidence that these fat depots contribute to insulin resistance.”
BackgroundThe Definition and Prevalence of Obesity and Metabolic Syndrome
Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_1 · Cited by 1,180
Adipocyte dysfunction, inflammation and metabolic syndrome
Klöting, N., & Blüher, M. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9301-0 · Cited by 472
Self-citationAdipose tissue dysfunction contributes to obesity related metabolic diseases
Blüher, M. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.02.005 · Cited by 408
Self-citationRey‐López, J. P., de Rezende, L. F., Pastor‐Valero, M., & Tess, B. H. (2014) · Obesity Reviews · doi:10.1111/obr.12198 · Cited by 310
Economic costs of overweight and obesity
Lehnert, T., Sonntag, D., Konnopka, A., Riedel-Heller, S., & König, H.-H. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.01.002 · Cited by 299
Toll-like Receptor Status in Obesity and Metabolic Syndrome: A Translational Perspective
Jialal, I., Kaur, H., & Devaraj, S. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3092 · Cited by 285
Sex dimorphism and depot differences in adipose tissue function
White, U. A., & Tchoukalova, Y. D. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.05.006 · Cited by 284
Aung, K., Lorenzo, C., Hinojosa, M. A., & Haffner, S. M. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2832 · Cited by 266
Fan, J., Song, Y., Chen, Y., Hui, R., & Zhang, W. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.230 · Cited by 266
Lipolysis in lipid turnover, cancer cachexia, and obesity-induced insulin resistance
Arner, P., & Langin, D. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.03.002 · Cited by 243
Guo, F., Moellering, D. R., & Garvey, W. T. (2014) · Obesity · doi:10.1002/oby.20585 · Cited by 202
“The CMDS system is shown in Table 1, and was based on results from the epidemiological and physiological literature: (i) Stage 0 includes individuals who are relatively insulin sensitive, free of any cardiometabolic disease risk factors, and without increased risk of diabetes or CVD (6), referred to as “metabolically…”
MECHANISMS IN ENDOCRINOLOGY: Are metabolically healthy obese individuals really healthy?
Blüher, M. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0540 · Cited by 177
Self-citationElffers, T. W., de Mutsert, R., Lamb, H. J., de Roos, A., Willems van Dijk, K., Rosendaal, F. R., Jukema, J. W., & Trompet, S. (2017) · PLOS ONE · doi:10.1371/journal.pone.0185403 · Cited by 167
Dankel, S. N., Svärd, J., Matthä, S., Claussnitzer, M., Klöting, N., Glunk, V., Fandalyuk, Z., Grytten, E., Solsvik, M. H., Nielsen, H., et al. (2014) · Obesity · doi:10.1002/oby.20758 · Cited by 95
“The cut-off for insulin sensitivity is supported by another study (20) and by a separate cohort consisting of 25 healthy individuals between 18 and 40 years of age, who all were insulin sensitive and showed GIR> 70 lmol kg(21) min(21) (8,21).”
MethodSelf-citationNormal physical activity obliterates the deleterious effects of a high-caloric intake
Krogh-Madsen, R., Pedersen, M., Solomon, T. P. J., Knudsen, S. H., Hansen, L. S., Karstoft, K., Lehrskov-Schmidt, L., Pedersen, K. K., Thomsen, C., Holst, J. J., et al. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00155.2013 · Cited by 53
“, preserved insulin sensitivity and relatively low visceral fat mass (8, 38).”
BackgroundAutonomic Blockade Improves Insulin Sensitivity in Obese Subjects
Gamboa, A., Okamoto, L. E., Arnold, A. C., Figueroa, R. A., Diedrich, A., Raj, S. R., Paranjape, S. Y., Farley, G., Abumrad, N., & Biaggioni, I. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03738 · Cited by 45
Metadata
- Authors
- Blüher, M.
- Venue
- Current Opinion in Endocrinology, Diabetes & Obesity
- Published
- 2012-10
- Volume
- 19
- Issue
- 5
- Pages
- 341-346
- ISSN
- 1752-296X (ISSN-L)
- OpenAlex
- W2113194585
- Cited by
- 157
- References
- 15
- FWCI
- 17.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.